Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JiaWeiLiuJunZiTang (JWLJZT) is a modified traditional Chinese medicine (TCM) herbal formula derived from the classic LiuJunZiTang (Six-Gentlemen Decoction). It is primarily investigated for the treatment of non-motor symptoms (NMS) in patients with idiopathic Parkinson's disease. The base formula consists of six core herbs: Panax ginseng, Atractylodes macrocephala, Poria cocos, Glycyrrhiza uralensis, Citrus reticulata, and Pinellia ternata. The JiaWei (modified) version typically incorporates additional botanical ingredients to address specific neurological and gastrointestinal manifestations of Parkinson's disease, such as constipation, sleep disturbances, and anxiety. JWLJZT is hypothesized to exert its therapeutic effects by modulating the gut-brain axis, potentially through the enhancement of ghrelin receptor signaling and neuroprotective mechanisms. Clinical research, including trials sponsored by the Food and Health Bureau of Hong Kong, has evaluated its safety and efficacy as an adjunctive therapy to standard dopaminergic treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiaweiliujunzitang.